This inventor holds 1 USPTO granted patent. Top assignee: Columbia University. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Francine Katz
Introduction: Francine Katz is a distinguished inventor based in New York, NY, recognized for her significant contributions to the field of neuroscience and pharmacology. With a strong focus on the activation and reactivation of acetylcholinesterase and butyrylcholinesterase, her innovative work addresses critical health issues such as organophosphate poisoning and nerve agent exposure.
Latest Patents: Francine Katz holds one notable patent titled "Activation or Reactivation of Ache." This patent details an in vitro or in vivo method for activating or reversing the inactivation of acetylcholinesterase (AChE) or butyrylcholinesterase (BuchE) through specific compounds. It also outlines methods for treating individuals exposed to nerve agents and for modulating neuronal signaling and transmission, which have vital implications for public health and safety.
Career Highlights: Katz is affiliated with Columbia University in the City of New York, where she continues to advance her research in neuroscience. Her work not only enhances understanding of cholinesterase-related mechanisms but also promotes the development of therapeutic strategies for acute poisoning scenarios.
Collaborations: Throughout her career, Francine Katz has collaborated with notable colleagues including Milan N. Stojanovic and Donald W. Landry. These partnerships have enriched her research initiatives and contributed to the growth of knowledge within her specialized field.
Conclusion: Francine Katz exemplifies the innovative spirit of contemporary inventors. Her work on the activation and reactivation of cholinesterases is not only groundbreaking but also crucial for addressing urgent health challenges. As she continues her research at Columbia University, the potential for her inventions to impact public health remains significant and inspirational.